...
机译:对三重阴性乳腺癌微小诊断,预测和治疗诊断,预测和治疗的视角
Cancer biology laboratory Department of Biochemistry and Bioinformatics GIS GITAM (Deemed to be University) Visakhapatnam Andhra Pradesh 530045 India;
Cancer biology laboratory Department of Biochemistry and Bioinformatics GIS GITAM (Deemed to be University) Visakhapatnam Andhra Pradesh 530045 India;
Cancer biology laboratory Department of Biochemistry and Bioinformatics GIS GITAM (Deemed to be University) Visakhapatnam Andhra Pradesh 530045 India;
Cancer biology laboratory Department of Biochemistry and Bioinformatics GIS GITAM (Deemed to be University) Visakhapatnam Andhra Pradesh 530045 India;
Cancer biology laboratory Department of Biochemistry and Bioinformatics GIS GITAM (Deemed to be University) Visakhapatnam Andhra Pradesh 530045 India;
Cancer biology laboratory Department of Biochemistry and Bioinformatics GIS GITAM (Deemed to be University) Visakhapatnam Andhra Pradesh 530045 India;
Cancer biology laboratory Department of Biochemistry and Bioinformatics GIS GITAM (Deemed to be University) Visakhapatnam Andhra Pradesh 530045 India;
TNBC; miRNA; Cancer biomarkers; miRNA-based therapy;
机译:对三重阴性乳腺癌微小诊断,预测和治疗诊断,预测和治疗的视角
机译:用于乳腺癌组织诊断和分期的新型高反应性Fab抗体还可区分出预后良好的三阴性乳腺癌子集
机译:微荷兰-9和微润罗纳-155在三重阴性乳腺癌中表达的预后价值
机译:新型靶向乳腺癌的细胞穿透肽偶联基因载体与治疗性microRNA的乳腺癌特异性递送。
机译:鉴定LRP8,CDCA7和MLK4作为三阴性乳腺癌中癌症干细胞的新疗法靶标
机译:三阴性乳腺癌的microRNA的诊断预后和治疗方法的观点
机译:用于乳腺癌组织诊断和分期的新型高反应性Fab抗体还可区分出预后良好的三阴性乳腺癌子集